Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

141. Pharmacoeconomic evaluation of Chronic Obstructive Pulmonary Disease (COPD) in Europe: a systematic review of the literature

Pharmacoeconomic evaluation of Chronic Obstructive Pulmonary Disease (COPD) in Europe: a systematic review of the literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

142. Non-pharmacological interventions for the management of fatigue in people with COPD: a systematic review

Non-pharmacological interventions for the management of fatigue in people with COPD: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

143. The cost-benefit ratio of physical and sporting activity for adults with COPD exposed to atmospheric pollution: systematic Review

The cost-benefit ratio of physical and sporting activity for adults with COPD exposed to atmospheric pollution: systematic Review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

144. The effectiveness of health education for the modification of habits and lifestyles and quality of life in older people diagnosed with COPD: a systematic review and meta-analysis

The effectiveness of health education for the modification of habits and lifestyles and quality of life in older people diagnosed with COPD: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2018 PROSPERO

145. Temporal trends in COPD exacerbation rates in placebo groups of clinical trials - a systematic review and meta-regression

Temporal trends in COPD exacerbation rates in placebo groups of clinical trials - a systematic review and meta-regression Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

146. Effects of breathing exercises in adults with Chronic Obstructive Pulmonary Disease (COPD)

Effects of breathing exercises in adults with Chronic Obstructive Pulmonary Disease (COPD) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

147. Hyperglycemia and adverse outcomes in acute exacerbation of COPD: a meta-analysis

Hyperglycemia and adverse outcomes in acute exacerbation of COPD: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

148. Efficacy and safety of Glycopyrrolate/Formoterol versus other long-acting ß2-agonist (LABA) or long-acting muscarinic antagonist (LAMA) fixed-dose combinations (FDCs) in COPD - a systematic review and meta-analysis

Efficacy and safety of Glycopyrrolate/Formoterol versus other long-acting ß2-agonist (LABA) or long-acting muscarinic antagonist (LAMA) fixed-dose combinations (FDCs) in COPD - a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated

2018 PROSPERO

149. Trelegy Ellipta - fluticasone furoate umeclidinium vilanterol - Chronic obstructive pulmonary disease (COPD)

Trelegy Ellipta - fluticasone furoate umeclidinium vilanterol - Chronic obstructive pulmonary disease (COPD) fluticasone furoate/umeclidinium/vilanterol | CADTH.ca Find the information you need fluticasone furoate/umeclidinium/vilanterol fluticasone furoate/umeclidinium/vilanterol Last Updated: September 19, 2018 Result type: Reports Project Number: SR0562-000 Product Line: Generic Name: fluticasone furoate umeclidinium vilanterol Brand Name: Trelegy Ellipta Manufacturer: GlaxoSmithKline Inc (...) . Indications: Chronic obstructive pulmonary disease (COPD) Manufacturer Requested Reimbursement Criteria 1 : For the long-term, once daily, maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, where the following clinical criteria are met: - Moderate to severe COPD as defined by spirometry; and - At risk of exacerbations despite a long-acting bronchodilator (LAMA or LABA); or - Symptomatic or at risk of exacerbations despite a LAMA/LABA

2018 Canadian Agency for Drugs and Technologies in Health - Common Drug Review

150. General medicine: Tiotropium could provide benefits in the early stage of COPD, but further studies are needed

General medicine: Tiotropium could provide benefits in the early stage of COPD, but further studies are needed Tiotropium could provide benefits in the early stage of COPD, but further studies are needed | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Tiotropium could provide benefits in the early stage of COPD, but further studies are needed Article Text Commentary General medicine Tiotropium could provide benefits in the early stage

2018 Evidence-Based Medicine

151. LAMA & LAMA/LABA for chronic obstructive pulmonary disease (COPD)

LAMA & LAMA/LABA for chronic obstructive pulmonary disease (COPD) '); } else { document.write(' '); } ACE | LAMA & LAMA/LABA for Chronic obstructive pulmonary disease (COPD) Search > > LAMA & LAMA/LABA for chronic obstructive pulmonary disease (COPD) - LAMA & LAMA/LABA for chronic obstructive pulmonary disease (COPD) Published on 2 July 2018 Guidance Recommendations The Ministry of Health’s Drug Advisory Committee has recommended: Umeclidinium 62.5mcg inhalation powder for the: Maintenance (...) /vilanterol) for maintenance treatment of stable chronic obstructive pulmonary disease (COPD). The Agency for Care Effectiveness conducted the evaluation in consultation with the MOH COPD Expert Working Group comprising senior healthcare professionals from the public healthcare institutions. The use of any LAMA or LAMA/LABA combination for the treatment of asthma was outside the scope of this evaluation. 1.2 By request of the manufacturer, aclidinium (LAMA) and aclidinium/formoterol (LAMA/LABA) were

2018 Appropriate Care Guides, Agency for Care Effectiveness (Singapore)

152. The value of endoscopic lung volume reduction for severe copd with emphysema using endobronchialvalves: a systematic review and meta-analysis

The value of endoscopic lung volume reduction for severe copd with emphysema using endobronchialvalves: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

153. The effectiveness of mindfulness-based interventions in patients with copd: asystematic review and meta-analysis

The effectiveness of mindfulness-based interventions in patients with copd: asystematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

154. Systematic review protocol: factors associated with COPD medication non-adherence to inhaler and oral medication

Systematic review protocol: factors associated with COPD medication non-adherence to inhaler and oral medication Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

155. Qualitative systematic review and meta-synthesis of self-management support preferences of people with COPD and asthma and their caregivers

Qualitative systematic review and meta-synthesis of self-management support preferences of people with COPD and asthma and their caregivers Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

156. Management of chronic obstructive pulmonary disease (copd) in adults - a systematic review of cost-effectiveness

Management of chronic obstructive pulmonary disease (copd) in adults - a systematic review of cost-effectiveness Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

157. Home-based exercise training for patients hospitalised with acute exacerbations of COPD - a systematic review

Home-based exercise training for patients hospitalised with acute exacerbations of COPD - a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2018 PROSPERO

158. Medical imaging at exacerbation of COPD

Medical imaging at exacerbation of COPD Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures

2018 PROSPERO

159. Effects of breathing exercises in patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis

Effects of breathing exercises in patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

160. Dietary patterns and respiratory health in COPD and asthma: a systematic review and meta-analysis

Dietary patterns and respiratory health in COPD and asthma: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO